LSK BioPartners, Inc. — Form D
LSK BioPartners, Inc. of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-01. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-08-01
- Form: D
- Accession: 0001748803-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 1
- Date of first sale: 2018-07-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-318276
Issuer
- Name: LSK BioPartners, Inc.
- CIK: 0001748803
- Entity type: Corporation
- Jurisdiction: UTAH
- Address: 2825 E Cottonwood Pkwy, SALT LAKE CITY, UT, 84121
- Phone: 801-303-7440
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Weili Cheng | Director | Salt Lake City, UT |
| Alex Kim | Director | Long Island City, NY |
| Sung Chul Kim | Director | Salt Lake City, UT |
| Sung Chul Kim | Executive Officer | Salt Lake City, UT |
| Ha Young Kim | Director | Salt Lake City, UT |
| Anton Gueth | Director | Salt Lake City, UT |
| Soo Whan Choi | Director | Salt Lake City, UT |
| Soo Whan Choi | Executive Officer | Salt Lake City, UT |
Other filings by this issuer (1)
More